RT Journal Article
SR Electronic
T1 Long stability of SARS-CoV-2 RNA in dry and saliva swab samples stored for diagnostics, Denmark
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.11.21251563
DO 10.1101/2021.02.11.21251563
A1 Alonzo Alfaro-Núñez
A1 Stephanie Crone
A1 Shila Mortensen
A1 Maiken Worsøe Rosenstierne
A1 Anders Fomsgaard
A1 Ellinor Marving
A1 Sofie Holdflod Nielsen
A1 Michelle Grace Pinto Jørgensen
A1 Arieh S. Cohen
A1 Claus Nielsen
YR 2021
UL http://medrxiv.org/content/early/2021/02/12/2021.02.11.21251563.abstract
AB During the current COVID-19 pandemic, Danish authorities demand that clinical swab samples must be analysed within 72 hours. This time constraint was adopted to guarantee a quick and efficient response. As today, analysis results are given within 20 hours average fulfilling this demand. However, it is unclear for how long and under which conditions swab specimens can be stored without clinically affecting SARS-CoV-2 RNA stability. This study demonstrates that swabs specimens can be stored at −20°C and +4°C for up to 26 days without affecting RT-qPCR results. However, early detection of asymptomatic cases is important to reduce spreading COVID-19 may be the final consequence not only in Denmark but worldwide.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was given to this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Exemption for review by the ethical committee system and informed consent was given by the Committee on Biomedical Research Ethics - Capital region in accordance with Danish law on assay development projects (see Journal-nr.: H-21000338).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated in this study is provided as supplemental materials.